Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
560122, C07C 6974, A61K 31235
A novel salicylic acid ester is described, which may be combined with inorganic or organic bases to give pharmaceutically acceptable salts. Such an ester is obtained by reaction of (-) campholenic acid chloride, as prepared by a well known technique, with salicylic acid.
There are, further, described pharmaceutical compositions having mucosecretolytic, anti-inflammatory, analgesic, antipyretic activity, which contain the novel ester or the salts thereof.
patent: 2561193 (1951-07-01), Fry
patent: 2835697 (1958-05-01), Murray
patent: 3519678 (1970-07-01), Farrington
patent: 3673237 (1972-06-01), Janiak
Camillo Corvi S.p.A.
Scott Patricia M.
(-) Campholenic acid ester of salicylic acid and pharmaceuticall does not yet have a rating. At this time, there are no reviews or comments for this patent.If you have personal experience with (-) Campholenic acid ester of salicylic acid and pharmaceuticall, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (-) Campholenic acid ester of salicylic acid and pharmaceuticall will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-172007